Our accumulated evidence suggests that the loss of TBK1 and IKKε may sensitize tumor cells to T cell killing and is associated with reduced pro-survival RIPK1 S25 phosphorylation within the TNFR1 complex, thereby promoting RIPK1 activation and subsequent cell death. Here, RIPK1 is linked to neoplasm.